Theacrine (TeaCrine)
Updated October 11, 2026 · By Sophie Callahan
The Short Answer
Theacrine (marketed as TeaCrine) is a purine alkaloid structurally similar to caffeine, found naturally in Kucha tea (Camellia assamica var. kucha). It has gained attention in the nootropic space for its potential to enhance energy and focus without the tolerance buildup associated with caffeine. A 2016 study tested 200 mg/day over 8 weeks and found sustained subjective improvements in energy without habituation. Clinical evidence is still limited compared to caffeine, with fewer published human trials.
What is Theacrine (TeaCrine)?
Theacrine (1,3,7,9-tetramethyluric acid) is a purine alkaloid that occurs naturally in the leaves of Kucha tea, a variety of Camellia assamica grown in Yunnan, China. It is structurally related to caffeine — in fact, caffeine is a biosynthetic precursor to theacrine in the plant. The branded form TeaCrine is a synthetically produced version used in most commercial supplements. Despite its structural similarity to caffeine, theacrine appears to have a distinct pharmacological profile, particularly regarding tolerance development.
How it works
Theacrine acts on adenosine receptors and dopamine signaling pathways, similar to caffeine, but with notable differences. It appears to antagonize adenosine A1 and A2A receptors (promoting wakefulness and alertness) while also activating dopamine D1 and D2 receptors (contributing to motivation and mood). The key differentiator from caffeine is that animal studies suggest theacrine does not produce locomotor sensitization — the mechanism behind caffeine tolerance. This has led to the hypothesis that theacrine may provide sustained energy and focus benefits without requiring dose escalation over time, though long-term human data is limited.
What the evidence says
The clinical evidence base for theacrine is smaller than for caffeine or traditional nootropic herbs. Most published data comes from safety studies and short-term efficacy trials.
- Theacrine at 200 mg/day maintained subjective improvements in energy and focus over 8 weeks without habituation. — A study evaluating 200 mg/day of TeaCrine (theacrine) over 8 weeks, measuring changes in energy, focus, motivation, and signs of tolerance development. (Kuhman et al., 2016)
Effective dosage
The limited clinical data uses 200–300 mg/day. A 2016 study by Kuhman et al. tested 200 mg/day of TeaCrine over 8 weeks and found sustained subjective improvements in energy, focus, and motivation without habituation. Safety studies have tested up to 400 mg/day without serious adverse events. Theacrine can be taken with or without food and is often combined with caffeine in nootropic formulas — some evidence suggests the combination enhances the effects of both compounds.
Safety and interactions
Theacrine appears well tolerated at doses up to 400 mg/day in published safety studies. Side effects are similar to mild caffeine effects: occasional jitteriness or stomach discomfort. Because it shares structural features with caffeine, it may interact with caffeine-sensitive conditions. Long-term safety data beyond 8 weeks is not available in published literature. Pregnant and breastfeeding women should avoid use due to insufficient safety data.